Chemed PE Ratio 2012-2025 | CHE
Current and historical p/e ratio for Chemed (CHE) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Chemed PE ratio as of April 15, 2026 is 19.57.
| Chemed PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-04-16 | 382.88 | 20.84 | |
| 2025-12-31 | 427.32 | $18.37 | 23.26 |
| 2025-09-30 | 446.56 | $18.89 | 23.64 |
| 2025-06-30 | 484.98 | $19.43 | 24.96 |
| 2025-03-31 | 612.32 | $20.51 | 29.85 |
| 2024-12-31 | 526.73 | $19.89 | 26.48 |
| 2024-09-30 | 596.95 | $19.80 | 30.15 |
| 2024-06-30 | 538.49 | $19.73 | 27.29 |
| 2024-03-31 | 636.62 | $18.59 | 34.25 |
| 2023-12-31 | 579.52 | $17.93 | 32.32 |
| 2023-09-30 | 514.70 | $16.15 | 31.87 |
| 2023-06-30 | 536.04 | $15.00 | 35.74 |
| 2023-03-31 | 531.78 | $15.89 | 33.47 |
| 2022-12-31 | 504.39 | $16.53 | 30.51 |
| 2022-09-30 | 431.06 | $17.18 | 25.09 |
| 2022-06-30 | 463.11 | $17.95 | 25.80 |
| 2022-03-31 | 499.41 | $17.06 | 29.27 |
| 2021-12-31 | 521.18 | $16.85 | 30.93 |
| 2021-09-30 | 457.88 | $19.02 | 24.07 |
| 2021-06-30 | 466.74 | $18.61 | 25.08 |
| 2021-03-31 | 451.99 | $20.11 | 22.48 |
| 2020-12-31 | 523.14 | $19.48 | 26.86 |
| 2020-09-30 | 471.48 | $16.50 | 28.57 |
| 2020-06-30 | 442.44 | $15.92 | 27.79 |
| 2020-03-31 | 424.63 | $13.99 | 30.35 |
| 2019-12-31 | 430.26 | $13.31 | 32.33 |
| 2019-09-30 | 408.70 | $12.58 | 32.49 |
| 2019-06-30 | 352.91 | $12.08 | 29.21 |
| 2019-03-31 | 312.75 | $12.27 | 25.49 |
| 2018-12-31 | 276.55 | $12.23 | 22.61 |
| 2018-09-30 | 311.70 | $12.29 | 25.36 |
| 2018-06-30 | 313.57 | $11.36 | 27.60 |
| 2018-03-31 | 265.65 | $6.74 | 39.41 |
| 2017-12-31 | 236.34 | $5.86 | 40.33 |
| 2017-09-30 | 196.26 | $4.49 | 43.71 |
| 2017-06-30 | 198.38 | $3.98 | 49.84 |
| 2017-03-31 | 176.97 | $6.81 | 25.99 |
| 2016-12-31 | 155.16 | $6.48 | 23.94 |
| 2016-09-30 | 136.19 | $6.28 | 21.69 |
| 2016-06-30 | 131.36 | $6.31 | 20.82 |
| 2016-03-31 | 130.28 | $6.38 | 20.42 |
| 2015-12-31 | 143.82 | $6.33 | 22.72 |
| 2015-09-30 | 127.94 | $6.30 | 20.31 |
| 2015-06-30 | 125.46 | $6.04 | 20.77 |
| 2015-03-31 | 114.06 | $5.85 | 19.50 |
| 2014-12-31 | 100.75 | $5.57 | 18.09 |
| 2014-09-30 | 97.91 | $5.15 | 19.01 |
| 2014-06-30 | 88.99 | $4.70 | 18.93 |
| 2014-03-31 | 84.74 | $4.11 | 20.62 |
| 2013-12-31 | 72.42 | $4.16 | 17.41 |
| 2013-09-30 | 67.40 | $4.27 | 15.78 |
| 2013-06-30 | 68.08 | $4.40 | 15.47 |
| 2013-03-31 | 74.98 | $4.73 | 15.85 |
| 2012-12-31 | 64.16 | $4.62 | 13.89 |
| 2012-09-30 | 64.62 | $4.51 | 14.33 |
| 2012-06-30 | 56.21 | $4.48 | 12.55 |
| 2012-03-31 | 58.13 | $4.32 | 13.46 |
| 2011-12-31 | 47.37 | $4.10 | 11.55 |
| 2011-09-30 | 50.69 | $3.80 | 13.34 |
| 2011-06-30 | 60.26 | $3.67 | 16.42 |
| 2011-03-31 | 61.14 | $3.55 | 17.22 |
| 2010-12-31 | 58.17 | $3.55 | 16.38 |
| 2010-09-30 | 52.05 | $3.36 | 15.49 |
| 2010-06-30 | 49.79 | $3.29 | 15.13 |
| 2010-03-31 | 49.45 | $3.23 | 15.31 |
| 2009-12-31 | 43.52 | $3.24 | 13.43 |
| 2009-09-30 | 39.72 | $3.26 | 12.18 |
| 2009-06-30 | 35.63 | $3.16 | 11.28 |
| 2009-03-31 | 35.06 | $3.08 | 11.38 |
| 2008-12-31 | 35.79 | $2.88 | 12.43 |
| 2008-09-30 | 36.89 | $2.79 | 13.22 |
| 2008-06-30 | 32.85 | $2.79 | 11.78 |
| 2008-03-31 | 37.81 | $2.49 | 15.18 |
| 2007-12-31 | 50.00 | $2.46 | 20.33 |
| 2007-09-30 | 55.56 | $2.40 | 23.15 |
| 2007-06-30 | 59.19 | $1.96 | 30.20 |
| 2007-03-31 | 43.67 | $2.06 | 21.20 |
| 2006-12-31 | 32.95 | $1.90 | 17.34 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $5.639B | $2.530B |
| Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |